Clinical Trial Update: THE EFFECT OF NEBULIZED AZITHROMYCIN AS THERAPY FOR BRONCHOPULMONARY DYSPLASIA [Phase 4]

View source ↗

Summary

Phase 4 study evaluating nebulized azithromycin for bronchopulmonary dysplasia in premature infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• Nebulized azithromycin (azithromycin)

Snippet

Sponsor: Alexandria University | Conditions: Bronchopulmonary Dysplasia, Premature | Phase 4 | Status: COMPLETED